Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH5 | P11766 | 2/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 8/20 | 0.46 |
| ▸ | POLB | P06746 | 4/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MYC | P01106 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1836093 | 0.88 | ADH5 (0.72) | ADH5CYP2C19MAPTPOLBTP53 | |
| SCHEMBL245000 | 0.88 | ADH5 (0.74) | ADH5CYP2C19MAPTPOLBTP53 | |
| SCHEMBL243967 | 0.86 | ADH5 (0.72) | ADH5CYP2C19MAPTPOLBTP53 | |
| SCHEMBL246638 | 0.86 | ADH5 (0.79) | ADH5CYP2C19MAPTPOLBTP53 | |
| SCHEMBL240913 | 0.85 | ADH5 (0.80) | ADH5CYP2C19MAPTPOLBTP53 | |
| SCHEMBL244714 | 0.84 | ADH5 (0.69) | ADH5CYP2C19MAPTPOLBTP53 | |
| N6022 SCHEMBL244480 | 0.83 | ADH5 (1.00) | ADH5CYP2C19MAPTPOLBTP53 | |
| N6022 SCHEMBL29502874 | 0.83 | ADH5 (1.00) | ADH5CYP2C19MAPTPOLBTP53 | |
| SCHEMBL245189 | 0.83 | ADH5 (0.78) | ADH5CYP2C19MAPTPOLBTP53 | |
| SCHEMBL25589058 | 0.82 | ADH5 (0.75) | ADH5CYP2C19MAPTPOLBTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013006658-A1 | TREATMENT OF ACETAMINOPHEN-INDUCED LIVER DAMAGE BY THE ADMINISTRATION OF MODULATORS OF NITRIC OXIDE | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2013-01-10 | — | — | WO | disclosed |
| EP-2318006-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 Pharmaceuticals, LLC (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010019903-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 PHARMACEUTICALS, LLC (US) | 2010-02-18 | — | — | WO | disclosed |